(Q34555382)

3 August 2017

1 reference

title

Molecular mechanisms activating muscle protein degradation in chronic kidney disease and other catabolic conditions (English)

1 reference

chronic renal insufficiency

3 August 2017

1 reference

Du J

1

1 reference

PubMed ID

15733069

3 August 2017

Hu Z

series ordinal

2

1 reference

PubMed ID

15733069

3 August 2017

Mitch WE

series ordinal

3

1 reference

3 August 2017

1 March 2005

1 reference

European Journal of Clinical Investigation

3 August 2017

1 reference

3 August 2017

35

1 reference

3 August 2017

3

1 reference

3 August 2017

157-163

1 reference

Factors predicting malnutrition in hemodialysis patients: a cross-sectional study.

3 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01473.X

Inflammation and reduced albumin synthesis associated with stable decline in serum albumin in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01473.X

Correction of metabolic acidosis increases serum albumin concentrations and decreases kinetically evaluated protein intake in haemodialysis patients: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01473.X

Effect of intravenous insulin treatment on in vivo whole body leucine kinetics and oxygen consumption in insulin-deprived type I diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01473.X

Interleukin-6 induces skeletal muscle protein breakdown in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01473.X

The effect of uraemia, acidosis, and dialysis treatment on protein metabolism: a longitudinal leucine kinetic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01473.X

Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01473.X

Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01473.X

Glucose Intolerance and Aging: Evidence for Tissue Insensitivity to Insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01473.X

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01473.X

Identification of ubiquitin ligases required for skeletal muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01473.X

Nutrition in CAPD: serum bicarbonate and the ubiquitin-proteasome system in muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01473.X

Increased mRNA levels for components of the lysosomal, Ca2+-activated, and ATP-ubiquitin-dependent proteolytic pathways in skeletal muscle from head trauma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01473.X

Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01473.X

The ubiquitin-proteasome proteolytic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01473.X

Regulation of muscle protein degradation: coordinated control of apoptotic and ubiquitin-proteasome systems by phosphatidylinositol 3 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01473.X

A predictive scale for evaluating cyclin-dependent kinase substrates. A comparison of p34cdc2 and p33cdk2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01473.X

Role of calpain in skeletal-muscle protein degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01473.X

The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01473.X

Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01473.X

Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01473.X

Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01473.X

Angiotensin II Induces Skeletal Muscle Wasting through Enhanced Protein Degradation and Down-Regulates Autocrine Insulin-Like Growth Factor I

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01473.X

10.1111/J.1365-2362.2005.01473.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

15733069